Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43.4M
-
Number of holders
-
37
-
Total 13F shares, excl. options
-
3.15M
-
Shares change
-
+1.31M
-
Total reported value, excl. options
-
$37.3M
-
Value change
-
+$15.4M
-
Number of buys
-
30
-
Number of sells
-
-5
-
Price
-
$11.86
Significant Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q2 2018
38 filings reported holding CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share as of Q2 2018.
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.15M shares
of 43.4M outstanding shares and own 7.25% of the company stock.
Largest 10 shareholders include BlackRock Inc. (882K shares), VANGUARD GROUP INC (668K shares), Nantahala Capital Management, LLC (424K shares), STATE STREET CORP (217K shares), First Eagle Investment Management, LLC (195K shares), NORTHERN TRUST CORP (180K shares), GEODE CAPITAL MANAGEMENT, LLC (110K shares), Bank of New York Mellon Corp (44.5K shares), MORGAN STANLEY (40.8K shares), and TIAA CREF INVESTMENT MANAGEMENT LLC (38.8K shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.